REPLICEL LIFE SCIENCES INC.

Profile

Company Names

REPLICEL LIFE SCIENCES INC.

Addresses

SUITE 900 - 570 GRANVILLE STREET, VANCOUVER BC, A1 V6C 3P1

SUITE 2020 - 401 WEST GEORGIA STREET, VANCOUVER BC, A1 V6B 5A1

SUITE 1225 - 888 DUNSMUIR STREET, VANCOUVER BC, A1 V6K 3C4

Phone Numbers

604-248-8693
604-248-8730
604-248-8697

 

Entity Type:

CORPORATION

Industry:

OTHER TECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

BRITISH COLUMBIA, CANADA

Total Amount Raised:

$5,811,925.00

Number of Funding Rounds:

23
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
23
2024-11-26 
$223,665.00 
$223,665.00 
$0.00 
Equity 
22
2023-03-14 
$740,778.00 
$740,778.00 
$0.00 
Equity 
21
2023-02-01 
$9,196.00 
$9,196.00 
$0.00 
Equity 
20
2023-01-17 
$86,942.00 
$86,942.00 
$0.00 
Equity 
19
2022-12-30 
$558,837.00 
$558,837.00 
$0.00 
Equity 
18
2022-05-04 
$592,728.00 
$592,728.00 
$0.00 
Equity 
17
2021-12-17 
$777,659.00 
$777,659.00 
$0.00 
Equity 
16
2021-06-02 
$161,520.00 
$161,520.00 
$0.00 
Equity 
15
2021-05-17 
$9,012.00 
$9,012.00 
$0.00 
Equity 
14
2021-02-08 
$385,848.00 
$385,848.00 
$0.00 
Equity 
13
2020-08-18 
$118,181.00 
$118,181.00 
$0.00 
Equity 
12
2020-07-15 
$447,064.00 
$447,064.00 
$0.00 
Equity 
11
2019-10-29 
$135,078.00 
$135,078.00 
$0.00 
Equity 
10
2019-09-10 
$76,030.00 
$76,030.00 
$0.00 
Equity 
9
2019-01-15 
$20,883.00 
$20,883.00 
$0.00 
Equity 
8
2017-10-19 
$267,158.00 
$267,158.00 
$0.00 
Equity 
7
2016-12-28 
$8,536.00 
$8,536.00 
$0.00 
Equity 
6
2016-10-28 
$112,274.00 
$112,274.00 
$0.00 
Equity 
5
2015-06-25 
$143,033.00 
$143,033.00 
$0.00 
Equity 
4
2013-04-10 
$70,210.00 
$70,210.00 
$0.00 
Equity 
3
2012-05-17 
$245.00 
$245.00 
$0.00 
 
2
2012-04-18 
$594,050.00 
$594,050.00 
$0.00 
Equity 
1
2012-03-29 
$272,998.00 
$272,998.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BEN 
 
AUSTRING 
EXECUTIVE OFFICER
REPLICEL LIFE SCIENCES INC.
GARY 
 
BODDINGTON 
DIRECTOR
REPLICEL LIFE SCIENCES INC.
LEE 
 
BUCKLER 
EXECUTIVE OFFICER, DIRECTOR
REPLICEL LIFE SCIENCES INC.
JOHN 
RICHARD 
CHALLIS 
DIRECTOR
REPLICEL LIFE SCIENCES INC.
JOHN 
RICHARD GEORGE 
CHALLIS 
DIRECTOR
REPLICEL LIFE SCIENCES INC.
DAVID 
 
HALL 
EXECUTIVE OFFICER, DIRECTOR
NATIONAL MERCHANT SERVICES, LLC   |  MYOUTDOORTV.COM CORP   |  SOUTHWESTERN AMBULATORY SURGERY CENTER, LLC   |  3 DAY BLINDS CORP   |  REPLICEL LIFE SCIENCES INC.   |  MEDGOLD RESOURCES CORP.   |  INDEX VENTURES VII (JERSEY), L.P.   |  INDEX VENTURES VII PARALLEL ENTREPRENEUR FUND (JERSEY), L.P.   |  INDEX VENTURES GROWTH III (JERSEY), L.P.   |  INDEX VENTURES VIII (JERSEY), L.P.   |  INDEX VENTURES VIII PARALLEL ENTREPRENEUR FUND (JERSEY), L.P.   |  HOLLYPORT SECONDARY OPPORTUNITIES VI LP   |  PARK + DIAMOND, INC.   |  RST, INC.   |  INDEX VENTURES GROWTH IV (JERSEY), L.P.   |  INDEX VENTURES IX (JERSEY), L.P.   |  INDEX VENTURES IX PARALLEL ENTREPRENEUR FUND (JERSEY), L.P.   |  NICHOLSON SAND INVESTORS LLC   |  MATILLION LTD   |  HOLLYPORT SECONDARY OPPORTUNITIES VII LP   |  HPT VII US LP   |  INDEX VENTURES X (JERSEY), L.P.   |  INDEX VENTURES GROWTH V (JERSEY), L.P.   |  INDEPENDENT PROPERTY GROUP, LLC   |  INDEX VENTURES GROWTH VI (JERSEY), L.P.   |  PLUS NONE, INC.
ROLF 
 
HOFFMAN 
EXECUTIVE OFFICER, DIRECTOR
REPLICEL LIFE SCIENCES INC.
ROLF 
 
HOFFMANN 
EXECUTIVE OFFICER
REPLICEL LIFE SCIENCES INC.
LARISSA 
 
HUANG 
DIRECTOR
REPLICEL LIFE SCIENCES INC.
PETER 
 
JENSEN 
EXECUTIVE OFFICER, DIRECTOR
EMPIRE WATER CORP   |  REPLICEL LIFE SCIENCES INC.   |  WEDDINGWIRE, INC.   |  BBOOTH, INC.   |  WESTKAM GOLD CORP.
TOM 
 
KORDYBACK 
EXECUTIVE OFFICER
SILVER SUN RESOURCE CORP.   |  REPLICEL LIFE SCIENCES INC.
DAVID 
 
KWOK 
EXECUTIVE OFFICER
REPLICEL LIFE SCIENCES INC.
PETER 
 
LEWIS 
DIRECTOR
MOTION COMPUTING INC   |  901 HOLDINGS, LLC   |  REPLICEL LIFE SCIENCES INC.   |  NABSYS INC   |  TAMARACK HOMEOWNERS ACQUISITION CO LLC   |  TRANSPLANT GENOMICS INC.
PETER 
 
LOWRY 
DIRECTOR
REPLICEL LIFE SCIENCES INC.
SIMON 
 
MA 
EXECUTIVE OFFICER
REPLICEL LIFE SCIENCES INC.   |  NORSEMAN CAPITAL LTD.
GEOFF 
 
MACKAY 
DIRECTOR
EGENESIS, INC.   |  REPLICEL LIFE SCIENCES INC.   |  GEMSTONE BIOTHERAPEUTICS, LLC   |  REDACTBIO, INC.   |  TALARIS THERAPEUTICS, INC.   |  SATELLOS BIOSCIENCE INC.
JAMIE 
 
MACKAY 
DIRECTOR
REPLICEL LIFE SCIENCES INC.
KEVIN 
 
MCELWEE 
EXECUTIVE OFFICER
REPLICEL LIFE SCIENCES INC.
HUGH 
 
ROGERS 
PROMOTER
KOOTENAY ZINC CORP.   |  REPLICEL LIFE SCIENCES INC.   |  TELO GENOMICS CORP.   |  EVOLVE CHARGING CORP.
ANDREW 
 
SCHUTTE 
DIRECTOR, EXECUTIVE OFFICER
REPLICEL LIFE SCIENCES INC.
GAVIN 
 
YE 
DIRECTOR
REPLICEL LIFE SCIENCES INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-12-16
D
Link
OTHER TECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2024-11-26 
2023-03-16
D
Link
OTHER TECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2023-03-14 
2023-02-08
D
Link
OTHER TECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2023-02-01 
2023-01-26
D
Link
OTHER TECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2023-01-17 
2023-01-06
D
Link
OTHER TECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2022-12-30 
2022-05-10
D
Link
OTHER TECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2022-05-04 
2021-12-20
D
Link
OTHER TECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2021-12-17 
2021-06-14
D/A
Link
OTHER TECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2021-06-02 
2021-06-03
D
Link
OTHER TECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2021-06-02 
2021-05-27
D
Link
OTHER TECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2021-05-17 
2021-02-26
D
Link
OTHER TECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2021-02-08 
2020-08-20
D
Link
OTHER TECHNOLOGY 
GOLD + SILVER ORES [1040] 
DECLINE TO DISCLOSE 
Equity 
2020-08-18 
2020-07-24
D
Link
OTHER TECHNOLOGY 
GOLD + SILVER ORES [1040] 
DECLINE TO DISCLOSE 
Equity 
2020-07-15 
2019-11-04
D
Link
OTHER TECHNOLOGY 
GOLD + SILVER ORES [1040] 
DECLINE TO DISCLOSE 
Equity 
2019-10-29 
2019-09-13
D
Link
OTHER TECHNOLOGY 
GOLD + SILVER ORES [1040] 
DECLINE TO DISCLOSE 
Equity 
2019-09-10 
2019-01-22
D
Link
OTHER TECHNOLOGY 
GOLD + SILVER ORES [1040] 
DECLINE TO DISCLOSE 
Equity 
2019-01-15 
2017-10-26
D
Link
OTHER TECHNOLOGY 
GOLD + SILVER ORES [1040] 
DECLINE TO DISCLOSE 
Equity 
2017-10-19 
2017-01-09
D
Link
OTHER TECHNOLOGY 
GOLD + SILVER ORES [1040] 
DECLINE TO DISCLOSE 
Equity 
2016-12-28 
2016-11-08
D
Link
OTHER TECHNOLOGY 
GOLD + SILVER ORES [1040] 
DECLINE TO DISCLOSE 
Equity 
2016-10-28 
2015-07-06
D
Link
OTHER TECHNOLOGY 
GOLD + SILVER ORES [1040] 
DECLINE TO DISCLOSE 
Equity 
2015-06-25 
2013-04-19
D
Link
OTHER TECHNOLOGY 
GOLD + SILVER ORES [1040] 
DECLINE TO DISCLOSE 
Equity 
2013-04-10 
2012-05-24
D
Link
OTHER TECHNOLOGY 
GOLD + SILVER ORES [1040] 
DECLINE TO DISCLOSE 
 
2012-05-17 
2012-04-25
D
Link
OTHER TECHNOLOGY 
GOLD + SILVER ORES [1040] 
DECLINE TO DISCLOSE 
Equity 
2012-04-18 
2012-04-04
D
Link
OTHER TECHNOLOGY 
GOLD + SILVER ORES [1040] 
DECLINE TO DISCLOSE 
Equity 
2012-03-29 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#